These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29074234)

  • 1. Development of a rapid and quantitative method for the analysis of viral entry and release using a NanoLuc luciferase complementation assay.
    Sasaki M; Anindita PD; Phongphaew W; Carr M; Kobayashi S; Orba Y; Sawa H
    Virus Res; 2018 Jan; 243():69-74. PubMed ID: 29074234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A split NanoLuc complementation-based human norovirus-like particle entry assay facilitates evaluation of anti-norovirus antibodies in live cells.
    Qiao W; Wang S; Zhang C; Huang Z
    Antiviral Res; 2022 Jan; 197():105231. PubMed ID: 34965447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly quantitative detection system for cell entry of human norovirus-like particles based on the complementation of NanoLuc luciferase.
    Kimura M; Sekiguchi K; Okitsu S; Ushijima H; Tani H
    Virology; 2022 Aug; 573():23-28. PubMed ID: 35691115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of tracking system for West Nile virus entry and evidence of microtubule involvement in particle transport.
    Makino Y; Suzuki T; Hasebe R; Kimura T; Maeda A; Takahashi H; Sawa H
    J Virol Methods; 2014 Jan; 195():250-7. PubMed ID: 24140187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.
    Puig-Basagoiti F; Deas TS; Ren P; Tilgner M; Ferguson DM; Shi PY
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4980-8. PubMed ID: 16304161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking of Human Parvovirus B19 Virus-Like Particles Using Short Peptide Tags Reveals a Membrane-Associated Extracellular Release of These Particles.
    Ishida K; Noguchi T; Kimura S; Suzuki H; Ebina H; Morita E
    J Virol; 2023 Feb; 97(2):e0163122. PubMed ID: 36749078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles.
    Kumar B; Hawkins GM; Kicmal T; Qing E; Timm E; Gallagher T
    Cells; 2021 Apr; 10(4):. PubMed ID: 33918600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors.
    Scholle F; Girard YA; Zhao Q; Higgs S; Mason PW
    J Virol; 2004 Nov; 78(21):11605-14. PubMed ID: 15479801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles.
    Harvey TJ; Liu WJ; Wang XJ; Linedale R; Jacobs M; Davidson A; Le TT; Anraku I; Suhrbier A; Shi PY; Khromykh AA
    J Virol; 2004 Jan; 78(1):531-8. PubMed ID: 14671135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity.
    Hanna SL; Pierson TC; Sanchez MD; Ahmed AA; Murtadha MM; Doms RW
    J Virol; 2005 Nov; 79(21):13262-74. PubMed ID: 16227249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.
    Pierson TC; Sánchez MD; Puffer BA; Ahmed AA; Geiss BJ; Valentine LE; Altamura LA; Diamond MS; Doms RW
    Virology; 2006 Mar; 346(1):53-65. PubMed ID: 16325883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a recombinant West Nile virus stably expressing the Gaussia luciferase for neutralization assay.
    Zhang PT; Shan C; Li XD; Liu SQ; Deng CL; Ye HQ; Shang BD; Shi PY; Lv M; Shen BF; Qin CF; Zhang B
    Virus Res; 2016 Jan; 211():17-24. PubMed ID: 26415755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of SPI-1 Dependent Type III Secretion and Injection Using a NanoLuc Luciferase-Based Assay.
    Pais SV; Westerhausen S; Bohn E; Wagner S
    Methods Mol Biol; 2022; 2427():57-71. PubMed ID: 35619025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus.
    Takahashi H; Ohtaki N; Maeda-Sato M; Tanaka M; Tanaka K; Sawa H; Ishikawa T; Takamizawa A; Takasaki T; Hasegawa H; Sata T; Hall WW; Kurata T; Kojima A
    Microbes Infect; 2009 Nov; 11(13):1019-28. PubMed ID: 19647801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. West Nile virus genome with glycosylated envelope protein and deletion of alpha helices 1, 2, and 4 in the capsid protein is noninfectious and efficiently secretes subviral particles.
    Roby JA; Hall RA; Khromykh AA
    J Virol; 2013 Dec; 87(23):13063-9. PubMed ID: 24049184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The luminescent HiBiT peptide enables selective quantitation of G protein-coupled receptor ligand engagement and internalization in living cells.
    Boursier ME; Levin S; Zimmerman K; Machleidt T; Hurst R; Butler BL; Eggers CT; Kirkland TA; Wood KV; Friedman Ohana R
    J Biol Chem; 2020 Apr; 295(15):5124-5135. PubMed ID: 32107310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.
    Holmes DA; Purdy DE; Chao DY; Noga AJ; Chang GJ
    J Clin Microbiol; 2005 Jul; 43(7):3227-36. PubMed ID: 16000440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of West Nile virus replicon expressing secreted Gaussia luciferase.
    Shan C; Li X; Deng C; Shang B; Xu L; Ye H; Yuan Z; Zhang B
    Virol Sin; 2013 Jun; 28(3):161-6. PubMed ID: 23709059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
    Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Kurata T; Sata T; Kojima A
    Vaccine; 2010 Sep; 28(40):6588-96. PubMed ID: 20678586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines.
    Fayzulin R; Scholle F; Petrakova O; Frolov I; Mason PW
    Virology; 2006 Jul; 351(1):196-209. PubMed ID: 16647099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.